Zobrazeno 1 - 10
of 20
pro vyhledávání: ''
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 35:563-569
Objective: To prevent postoperative relapse after HOLRBT, we compared postoperative adjuvant therapies. Methods: One hundred fifty patients with non-muscle invasive bladder cancer (NMIBC) were meanly divided into three groups: A, B, and C. Group A pa
Publikováno v:
Human Gene Therapy. 31:891-903
Oncolytic adenoviruses (OAds) are promising agents for cancer therapy, representing a novel therapeutic strategy for pancreatic ductal adenocarcinoma (PDAC). However, there are challenges associated with the successful use of an OAd alone, involving
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 34:436-443
The Wnt/β-catenin signaling pathway is one of the highly conserved signaling pathway widely reported to play essential roles in the development of various tumors and human cancers, thus serving as a potential target for anticancer therapy. However,
Autor:
Wei-Shan Hung, Hui-Ju Tsai, Ching-Ping Tseng, Hsing-Ying Lee, Yu-Ting Chen, Jen-Der Lin, Kong-Kit Leong, Hsueh-Ling Hsu, Ying-Ru Wang, Miaw-Jene Liou
Publikováno v:
Thyroid. 28:1479-1489
Thyroid cancer is the most common endocrine tumor and generally has relatively good clinical outcomes. However, 15-20% of patients ultimately develop recurrence or disease-related death. The appropriate prognostic factors for thyroid cancer are still
Autor:
Guang-Ping Qiu, Jie Liu
Publikováno v:
Genetic Testing and Molecular Biomarkers. 20:579-586
This study aimed to investigate the value of microRNA (miR) gene polymorphisms in evaluating the efficacy of transcatheter arterial chemoembolization (TACE) in primary hepatocellular carcinoma (HCC).A total of 507 patients with primary HCC were enrol
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 30:421-426
To assess the prognostic role of total lesion glycolysis (TLG) in patients with breast cancer liver metastases (BCLM) after sequential lobar (90)Y-radioembolization ((90)Y-RE). Seventeen patients with bilobar BCLM underwent FDG PET/CT and TLG calcula
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:753-757
Twenty-nine (29) patients with recurrent head and neck carcinomas underwent (125)I seed permanent implantation under ultrasonography guidance and the feasibility and efficacy of (125)I seed implantation were assessed. The postplan evaluation showed t
Autor:
Warren H. Fong, Louis A. VanderMolen, Robert O. Dillman, Khosrow Mahdavi, Neil M. Barth, Stephanie E. McClure
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:273-277
Interleukin-2 (IL-2) was the preferred treatment for medically fit patients with advanced kidney cancer, but recently, several targeted therapies have been approved for metastatic renal cell carcinoma. We wished to determine the long-term survival ra
Publikováno v:
DNA and Cell Biology. 30:17-24
Head and neck cancer (HNC) is a common cancer, and its prognosis has not changed during the last decades. Detection of the disease at an early stage is crucial for successful treatment, as early diagnosis can significantly increase the survival rate.
Autor:
Lu Wu, Meng-Chao Wu, Shuqun Shen, Feng Shen, Yefa Yang, Jun Liang, Nai-Jian Ge, Yi Wang, Wei-Ping Zhou
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 25:657-663
Few options are available to treat patients with hepatocellular carcinoma (HCC). It was tested whether the combination of iodine-131(¹³¹I)-metuximab with chemoembolization could improve outcomes in patients with intermediate HCC. Between April 200